ConductScience.org, home

Paper9307982

Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii.

Séguy N and 6 others. Mol Med, 1997. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii. Papers, record 9307982. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9307982

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii.
PubMed
Journal
Mol Med
PubMed
Year
1997
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2018-11-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Séguy NN
2Cailliez JCJ C
3Delcourt PP
4Conti SS
5Camus DD
6Dei-Cas EE
7Polonelli LL

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, FungalMajor topic
CandidaMajor topic
MycotoxinsMajor topic
PneumocystisMajor topic
Animals
Antibodies, Monoclonal
Antibody Specificity
Candidiasis, Vulvovaginal
Cell Adhesion
Female
Fibroblasts
Humans
Immunity, Innate
Killer Factors, Yeast
Lung
Male
Neutralization Tests
Pneumonia, Pneumocystis
Rats
Rats, Nude
Receptors, Cell Surface
Vagina

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13771773Reevaluation of the yeast killer phenomenon.J Clin Microbiol1986https://conductscience.org/library/papers/3771773PubMed
27815973The yeast killer phenomenon: a hypothetical way to control Pneumocystis carinii pneumonia.Med Hypotheses1994https://conductscience.org/library/papers/7815973PubMed
32451680Yeast killer toxin-like anti-idiotypic antibodies.J Clin Microbiol1988https://conductscience.org/library/papers/2451680PubMed
42642522Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolates.J Infect Dis1989https://conductscience.org/library/papers/2642522PubMed
52198575Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2198575PubMed
62201251Involvement of a cell wall receptor in the mode of action of an anti-Candida toxin of Pichia anomala.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2201251PubMed
72170534Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans.J Immunol Methods1990https://conductscience.org/library/papers/2170534PubMed
81985248Pneumocystis carinii--new clinical spectrum?N Engl J Med1991https://conductscience.org/library/papers/1985248PubMed
91854433Interfaces of the yeast killer phenomenon.Crit Rev Microbiol1991https://conductscience.org/library/papers/1854433PubMed
101682252Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon.Infect Immun1991https://conductscience.org/library/papers/1682252PubMed
111508039Pneumocystis carinii shows DNA homology with the ustomycetous red yeast fungi.Mol Microbiol1992https://conductscience.org/library/papers/1508039PubMed
121474452The fungal nature of Pneumocystis.J Med Vet Mycol1992https://conductscience.org/library/papers/1474452PubMed
138418467Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity.Scand J Immunol1993https://conductscience.org/library/papers/8418467PubMed
148144911Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.J Immunol1994https://conductscience.org/library/papers/8144911PubMed
158198382Pathogenesis and host response in Pneumocystis carinii pneumonia.Annu Rev Med1994https://conductscience.org/library/papers/8198382PubMed
167804202Susceptibility of Pneumocystis carinii to a Pichia anomala killer toxin.J Eukaryot Microbiol1994https://conductscience.org/library/papers/7804202PubMed
177724517Pneumocystitis carinii organisms from in vitro culture are highly infectious to the nude rat.Parasitol Res1995https://conductscience.org/library/papers/7724517PubMed
187728138Polymorphism of the thymidylate synthase gene of Pneumocystis carinii from different host species.J Eukaryot Microbiol1995https://conductscience.org/library/papers/7728138PubMed
198596040Human natural yeast killer toxin-like candidacidal antibodies.J Immunol1996https://conductscience.org/library/papers/8596040PubMed
208822831In vitro decrease of rat-derived Pneumocystis carinii attachment induced by human natural yeast killer toxin-like antiidiotypic candidacidal antibodies.J Eukaryot Microbiol1996https://conductscience.org/library/papers/8822831PubMed

See all 27 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
22675322Antibody Peptide based antifungal immunotherapy.Front Microbiol2012https://conductscience.org/library/papers/22675322PubMed
17709417Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma.Infect Immun2007https://conductscience.org/library/papers/17709417PubMed
11953373Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation.Infect Immun2002https://conductscience.org/library/papers/11953373PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9307982

GET https://conductscience.org/api/papers/v1/9307982/references?page=2